Macular Degeneration: all 1,489 studies
Page 6 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled SyringeCompletedNCT07214740Phase 3
- Prevalence and Determinants of Shoulder Girdle Musculoskeletal Complaints in Geriatric Patients With Diminished VisionCompletedNCT07206654
- Intravitreal Faricimab in Patients With Refractory Macular EdemaCompletedNCT07093385Phase 2
- A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular DegenerationActive, not recruitingNCT06970665Phase 4
- A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)TerminatedNCT06961370Phase 1
- Association Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome ProteomicsCompletedNCT06883461
- Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula EdemaCompletedNCT06878573
- 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationActive, not recruitingNCT06864988Phase 3
- Hyperspectral Drusen ClassificationCompletedNCT06860555
- A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular DegenerationActive, not recruitingNCT06825858Phase 1
- A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)Active, not recruitingNCT06817343Phase 1
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic AtrophyActive, not recruitingNCT06779773
- A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyActive, not recruitingNCT06722157Phase 2
- Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMDActive, not recruitingNCT06717139
- Ocular Safety and Usability Study for FYB203 PFSCompletedNCT06708637Phase 4
- Ocular Safety and Usability Study for FYB201 PFSCompletedNCT06708624Phase 4
- Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMDActive, not recruitingNCT06707753Phase 1/2
- NT-101 Topical Ophthalmic Solution in Patients With Wet AMDCompletedNCT06704009Phase 1/2
- A Study to Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD)CompletedNCT06699914
- Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous TreatmentCompletedNCT06683950Phase 4
- Evaluation of The Performance of Retinow AI SoftwareCompletedNCT06645964
- Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration PatientsActive, not recruitingNCT06582511
- Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD PatientsActive, not recruitingNCT06518512
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular DegenerationActive, not recruitingNCT06495918Phase 3
- A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVOCompletedNCT06495203
- An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World SettingWithdrawnNCT06398080
- Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis StudyCompletedNCT06391411Not applicable
- ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)Active, not recruitingNCT06373731Phase 3
- Ozonized Oil as Dietary Supplement in Macular DegenerationActive, not recruitingNCT06351033
- Robotic Subretinal tPA Injection StudyCompletedNCT06347107Not applicable
- Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual AcuityCompletedNCT06330220Phase 4
- A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular EdemaCompletedNCT06305416Phase 3
- Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)Active, not recruitingNCT06300476Phase 1/2
- Switching to Faricimab in Neovascular Age-related Macular Degeneration Resistant to Both Aflibercept and RanibizumabCompletedNCT06231121
- Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)Active, not recruitingNCT06229665Phase 2/3
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationActive, not recruitingNCT06223958Phase 3
- Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus ImagesCompletedNCT06213896
- LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)Active, not recruitingNCT06198413Phase 1
- Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)Active, not recruitingNCT06196840Phase 2
- Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)CompletedNCT06184360
- Device for Age-related Macular Degeneration (AMD)CompletedNCT06178978
- Injection Intervals in Real-world Neovascular Age-related Macular Degeneration (nAMD) Patients Switching to Brolucizumab With at Least 12 Months of Follow-upCompletedNCT06178770
- Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular DegenerationCompletedNCT06174181Not applicable
- Evaluation of Kamuvudine-8 in Subjects With Geographic AtrophyCompletedNCT06164587Phase 1/2
- Impact of Non-Exudative Type 1 MNV on AMD ProgressionActive, not recruitingNCT06125977
- Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept TreatmentsCompletedNCT06124677
- Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationActive, not recruitingNCT06087458Phase 1/2
- Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE StudyCompletedNCT06021366
- Ocular, Vascular, and Genetic Findings in AMD PatientsActive, not recruitingNCT06015633
- A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyCompletedNCT06006585Phase 1
- Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMDCompletedNCT05988827Not applicable
- NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular DegenerationActive, not recruitingNCT05984927Phase 1/2
- A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMDActive, not recruitingNCT05972473Phase 3
- Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVCCompletedNCT05969418
- Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy StudyCompletedNCT05963646
- Evaluation of IBI302 Injection in nAMD or DMESuspendedNCT05961007Phase 1/2
- Faricimab for High-frequent Aflibercept Treated Neovascular Age-related Macular DegenerationCompletedNCT05941715Phase 4
- A Study of the SING IMT in an Israeli CohortWithdrawnNCT05941273Not applicable
- The Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in PregnancyCompletedNCT05927740Not applicable
- Comparison of Ocular Changes by Surgical Menopause Using Optical Coherence Tomography (OCT)CompletedNCT05920655
- The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With MaculopathiesCompletedNCT05904444Not applicable
- A Study of EXG102-031 in Patients With wAMD (Everest)CompletedNCT05903794Phase 1
- Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).TerminatedNCT05893537Phase 2
- Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)Active, not recruitingNCT05859776Phase 1/2
- A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT05839041Phase 2
- Development and Validation of a Deep Learning-based Myopia and Myopic Maculopathy Detection and Prediction SystemCompletedNCT05835115
- A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in IndiaCompletedNCT05834075
- Safety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD)Status unknownNCT05831007Not applicable
- A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT05811351Phase 2
- Investigating Geographic Atrophy Insights (i-GAIN) Natural History StudyActive, not recruitingNCT05797896
- Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo ModelsCompletedNCT05793515
- Rehabilitating Vision Loss in Veterans With Age-Related Macular DegenerationWithdrawnNCT05780931
- MP-3 Biofeedback Training and Central Vision LossCompletedNCT05772780Not applicable
- Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy IndividualsActive, not recruitingNCT05763940Not applicable
- Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular DegenerationStatus unknownNCT05757674
- Prismatic Correction for Improving Near Visual Acuity in Patients With MaculopathyCompletedNCT05747417Not applicable
- Can the Risk for AMD be Modulated?Active, not recruitingNCT05735730Not applicable
- Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&ECompletedNCT05710471Phase 4
- Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular DegenerationCompletedNCT05703867Phase 1/2
- Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)Active, not recruitingNCT05698329Phase 1
- A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease ProgressionCompletedNCT05698316
- ForeseeHome NRich RegistryActive, not recruitingNCT05690880
- Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMDCompletedNCT05678517
- VISUPRIME® Eye DropsCompletedNCT05677685Not applicable
- MacuTest Website for Personalized AMD Risk Prediction and PreventionWithdrawnNCT05675917Not applicable
- Artificial Intelligence Diagnostic AidStatus unknownNCT05675540
- Function and Imaging Assessments for G1961E-associated Stargardt DiseaseActive, not recruitingNCT05674058
- Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid NeovasculopathyStatus unknownNCT05672979Phase 3
- Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85CompletedNCT05667688Phase 1
- Adherence to Lifestyle Changes for Age-related Macular DegenerationCompletedNCT05667441Not applicable
- Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCVCompletedNCT05662943
- Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular DegenerationActive, not recruitingNCT05657301Phase 1
- A Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular DegenerationCompletedNCT05639530Phase 1
- A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)CompletedNCT05637255Phase 2
- The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal InjectionsCompletedNCT05615805Not applicable
- Associations Between the Oral and Intestinal Microbiome and Neovascular Age-related Macular DegenerationCompletedNCT05604989Phase 3
- Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular DegenerationCompletedNCT05587062Phase 3
- OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular DegenerationStatus unknownNCT05569226
- Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral CameraStatus unknownNCT05566626Not applicable
- Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).Status unknownNCT05562336